glp 1 news today GLP-1 News: Latest Updates on Weight Loss and Diabetes Medications FDA approves once-daily GLP-1 weight
Description
So far, Novo Nordisks oral semaglutide and Lillys orforglipron are available
doi: 10.1038/nchembio.1665
With production ramped up, so too will be a likely effort by drugmakers to encourage their use, says Marc Sweeney, Founder & CEO of Profero Team
How to use it Liraglutide is FDA approved as adjunctive therapy to diet and exercise for weight management in adults with body mass index at or above 30 kg/m (or 27 kg/m with a weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia)
Hydration Dehydration is a stealth saboteur of GLP-1 results
